Plexin D1 as a Potential Biomarker inPM/DM

计划入组 66 人 · 首次发布于 2022 年 12 月 6 日

Plexin B2 Gene Expression and Polymorphisms in Psoriasis

计划入组 200 人 · 首次发布于 2022 年 1 月 11 日

Ephrin B1 Regulation in Human Right Appendage

计划入组 30 人 · 首次发布于 2010 年 3 月 4 日

EVX-B1

DA5221-B1

EXV-B1

JiangXi Tianxin Pharmaceutical Co., Ltd.

China

PLEXAA LTD

United Kingdom

Plexium, Inc.

United States

Vaccinex's Pepinemab Shows Promise in Alzheimer's Disease Trial

Vaccinex to Present New Biomarker Data Supporting Expanded Phase 2b Trial of Pepinemab in Early Alzheimer's Disease

Vaccinex's Pepinemab Shows Promise in Turning "Cold" Tumors "Hot" Through Enhanced Immune Response